These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17882530)

  • 1. Phospholamban overexpression in transgenic rabbits.
    Pattison JS; Waggoner JR; James J; Martin L; Gulick J; Osinska H; Klevitsky R; Kranias EG; Robbins J
    Transgenic Res; 2008 Apr; 17(2):157-70. PubMed ID: 17882530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
    Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
    J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.
    Zhai J; Schmidt AG; Hoit BD; Kimura Y; MacLennan DH; Kranias EG
    J Biol Chem; 2000 Apr; 275(14):10538-44. PubMed ID: 10744747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholamban-modulated Ca2+ transport in cardiac and slow twitch skeletal muscle sarcoplasmic reticulum.
    Movsesian MA; Morris GL; Wang JH; Krall J
    Second Messengers Phosphoproteins; 1992-1993; 14(3):151-61. PubMed ID: 1345340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure.
    Schmidt AG; Zhai J; Carr AN; Gerst MJ; Lorenz JN; Pollesello P; Annila A; Hoit BD; Kranias EG
    Cardiovasc Res; 2002 Nov; 56(2):248-59. PubMed ID: 12393095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
    Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
    J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between phospholamban and nucleotide activation of cardiac sarcoplasmic reticulum Ca2+ adenosinetriphosphatase.
    Coll KE; Johnson RG; McKenna E
    Biochemistry; 1999 Feb; 38(8):2444-51. PubMed ID: 10029538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse phospholamban gene expression during development in vivo and in vitro.
    Ganim JR; Luo W; Ponniah S; Grupp I; Kim HW; Ferguson DG; Kadambi V; Neumann JC; Doetschman T; Kranias EG
    Circ Res; 1992 Nov; 71(5):1021-30. PubMed ID: 1394867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of phospholamban in slow-twitch skeletal muscle is associated with depressed contractile function and muscle remodeling.
    Song Q; Young KB; Chu G; Gulick J; Gerst M; Grupp IL; Robbins J; Kranias EG
    FASEB J; 2004 Jun; 18(9):974-6. PubMed ID: 15059971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.
    Asahi M; Otsu K; Nakayama H; Hikoso S; Takeda T; Gramolini AO; Trivieri MG; Oudit GY; Morita T; Kusakari Y; Hirano S; Hongo K; Hirotani S; Yamaguchi O; Peterson A; Backx PH; Kurihara S; Hori M; MacLennan DH
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9199-204. PubMed ID: 15201433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the beta1-adrenergic receptor.
    Engelhardt S; Boknik P; Keller U; Neumann J; Lohse MJ; Hein L
    FASEB J; 2001 Dec; 15(14):2718-20. PubMed ID: 11606476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality.
    Dash R; Kadambi V; Schmidt AG; Tepe NM; Biniakiewicz D; Gerst MJ; Canning AM; Abraham WT; Hoit BD; Liggett SB; Lorenz JN; Dorn GW; Kranias EG
    Circulation; 2001 Feb; 103(6):889-96. PubMed ID: 11171800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cell-penetrating phospholamban-specific RNA aptamer enhances Ca2+ transients and contractile function in cardiomyocytes.
    Sakai H; Ikeda Y; Honda T; Tanaka Y; Shiraishi K; Inui M
    J Mol Cell Cardiol; 2014 Nov; 76():177-85. PubMed ID: 25240642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene.
    Tschöpe C; Spillmann F; Rehfeld U; Koch M; Westermann D; Altmann C; Dendorfer A; Walther T; Bader M; Paul M; Schultheiss HP; Vetter R
    FASEB J; 2004 Dec; 18(15):1967-9. PubMed ID: 15448111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of Lys27 instead of Asn27 in human phospholamban promotes sarcoplasmic reticulum Ca2+-ATPase superinhibition and cardiac remodeling.
    Zhao W; Yuan Q; Qian J; Waggoner JR; Pathak A; Chu G; Mitton B; Sun X; Jin J; Braz JC; Hahn HS; Marreez Y; Syed F; Pollesello P; Annila A; Wang HS; Schultz Jel J; Molkentin JD; Liggett SB; Dorn GW; Kranias EG
    Circulation; 2006 Feb; 113(7):995-1004. PubMed ID: 16476846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone enhances Ca2+ pumping activity of the cardiac sarcoplasmic reticulum by increasing Ca2+ ATPase and decreasing phospholamban expression.
    Kimura Y; Otsu K; Nishida K; Kuzuya T; Tada M
    J Mol Cell Cardiol; 1994 Sep; 26(9):1145-54. PubMed ID: 7815458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of sarcoplasmic reticulum gene expression during cardiac and skeletal muscle development.
    Arai M; Otsu K; MacLennan DH; Periasamy M
    Am J Physiol; 1992 Mar; 262(3 Pt 1):C614-20. PubMed ID: 1372478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human phospholamban gene: structure and expression.
    McTiernan CF; Frye CS; Lemster BH; Kinder EA; Ogletree-Hughes ML; Moravec CS; Feldman AM
    J Mol Cell Cardiol; 1999 Mar; 31(3):679-92. PubMed ID: 10198197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.
    Haghighi K; Gregory KN; Kranias EG
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1214-22. PubMed ID: 15336969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholamban and cardiac contractility.
    Frank K; Kranias EG
    Ann Med; 2000 Nov; 32(8):572-8. PubMed ID: 11127935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.